Inclusion Criteria:

- histologically confirmed aggressive or indolent, B-cell non-hodgkins lymphoma

- original enrollment in vaccine protocol for newly diagnosed lymphoma and had
successful production of idiotype vaccine

- failed to achieve PR or CR with initial induction chemotherapy, received salvage
chemotherapy and then stem cell transplant and achieved a CR or good PR following
transplantation

->/= 19 years

- signed informed consent

- non-pregnant, non-lactating

Exclusion Criteria:

- serious disease or condition that, in the opinion of the investigator, would
compromise the subject's ability to participate in the study.